Related Articles
Personalized treatment in the eradication therapy for Helicobacter pylori
Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after helicobacter pylori eradication
Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma
Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability
Second‑line triple therapy in failures with vonoprazan‑based triple therapy for eradication of Helicobacter pylori